Black Diamond Therapeutics Inc. (NASDAQ: BDTX)
$6.24
+0.2200 ( +3.65% ) 170.1K
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
Market Data
Open
$6.24
Previous close
$6.02
Volume
170.1K
Market cap
$352.24M
Day range
$5.89 - $6.26
52 week range
$1.62 - $7.66
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 12 | Jan 18, 2024 |
| 8-k | 8K-related | 57 | Jan 04, 2024 |
| 4 | Insider transactions | 1 | Dec 15, 2023 |
| 4 | Insider transactions | 1 | Dec 15, 2023 |
| 8-k | 8K-related | 14 | Dec 13, 2023 |
| 10-q | Quarterly Reports | 59 | Nov 06, 2023 |
| 8-k | 8K-related | 14 | Nov 06, 2023 |
| 4 | Insider transactions | 1 | Oct 19, 2023 |
| 4 | Insider transactions | 1 | Sep 18, 2023 |
| 8-k | 8K-related | 16 | Sep 18, 2023 |